OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
December 02, 2022
Manufacturing biopharmaceuticals in an aging facility may create quality issues such as equipment breakdown and contamination risks.
The design of viral clearance studies must keep pace with the quickly evolving biologic drugs industry.
December 01, 2022
Digitalization of bioprocessing is slowly bringing benefits to the biopharma industry.
Health crises, political tension, and budget concerns were major challenges.
From the Editor
mRNA may not be a train we necessarily all need to get onboard immediately, but we should know where the central train station is located, and what it connects us to.
From the CEO
Science news can be just so weird, or weirdly useful, that everything else recedes as we ponder whether it is true and what consequences it might bring.